Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?

被引：14

作者：

Polasik, Arkadius ^{[1
]}

Tzschaschel, Marie ^{[1
]}

Schochter, Fabienne ^{[1
]}

de Gregorio, Amelie ^{[1
]}

Friedl, Thomas W. P. ^{[1
]}

Rack, Brigitte ^{[1
]}

Hartkopf, Andreas ^{[2
]}

Fasching, Peter A. ^{[3
]}

Schneeweiss, Andreas ^{[4
]}

Mueller, Volkmar ^{[5
]}

Huober, Jens ^{[1
]}

Janni, Wolfgang ^{[1
]}

Fehm, Tanja ^{[6
]}

机构：

[1] Univ Klinikum Ulm, Klin Gynakol & Geburtshilfe, Ulm, Germany

[2] Univ Klinikum Tubingen, Klin Gynakol & Geburtshilfe, Tubingen, Germany

[3] Univ Klinikum Erlangen, Klin Gynakol & Geburtshilfe, Erlangen, Germany

[4] Univ Klinikum Heidelberg, Natl Ctr Tumorerkrankungen, Heidelberg, Germany

[5] Univ Klinikum Hamburg Eppendorf, Klin Gynakol & Geburtshilfe, Hamburg, Germany

[6] Heinrich Heine Univ Dusseldorf, Klin Gynakol & Geburtshilfe, Dusseldorf, Germany

来源：

GEBURTSHILFE UND FRAUENHEILKUNDE | 2017年 / 77卷 / 12期

关键词：

breast; Her-2/neu (human epidermal growth factor recptor); hormonal receptor; mammary gland tumor; metastasis; POOLED ANALYSIS; HER2; STATUS; ESTROGEN-RECEPTOR; PIK3CA MUTATIONS; ESR1; MUTATIONS; BONE-MARROW; RESISTANCE; DISEASE; MARKER; SITES;

D O I：

10.1055/s-0043-122884

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Dissemination of tumour cells and the development of solid metastases occurs via blood vessels and lymphatics. Circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) can be detected in venous blood in patients with early and metastatic breast cancer, and their prognostic relevance has been demonstrated on numerous occasions. Repeated testing for CTCs and ctDNA, or regular so-called "liquid biopsy", can be performed easily at any stage during the course of disease. Additional molecular analysis allows definition of tumour characteristics and heterogeneity that may be associated with treatment resistance. This in turn makes personalised, targeted treatments possible that may achieve both improved overall survival and quality of life.

引用

页码：1291 / 1298

页数：8

共 46 条

[31] D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer [J].

Merenbakh-Lamin, Keren ;

Ben-Baruch, Noa ;

Yeheskel, Adva ;

Dvir, Addie ;

Soussan-Gutman, Lior ;

Jeselsohn, Rinath ;

Yelensky, Roman ;

Brown, Myles ;

Miller, Vincent A. ;

Sarid, David ;

Rizel, Shulamith ;

Klein, Baruch ;

Rubinek, Tami ;

Wolf, Ido .

CANCER RESEARCH, 2013, 73 (23) :6856-6864

[32] Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study [J].

Mueller, Volkmar ;

Riethdorf, Sabine ;

Rack, Brigitte ;

Janni, Wolfgang ;

Fasching, Peter A. ;

Solomayer, Erich ;

Aktas, Bahriye ;

Kasimir-Bauer, Sabine ;

Pantel, Klaus ;

Fehm, Tanja .

BREAST CANCER RESEARCH, 2012, 14 (04)

[33] Changes of HER2 Status in Circulating Tumor Cells Compared With the Primary Tumor During Treatment for Advanced Breast Cancer [J].

Munzone, Elisabetta ;

Nole, Franco ;

Goldhirsch, Aron ;

Botteri, Edoardo ;

Esposito, Angela ;

Zorzino, Laura ;

Curigliano, Giuseppe ;

Minchella, Ida ;

Adamoli, Laura ;

Cassatella, Maria Cristina ;

Casadio, Chiara ;

Sandri, Maria Teresa .

CLINICAL BREAST CANCER, 2010, 10 (05) :392-397

[34]

Paget S., 1889, LANCET, V133, P571, DOI DOI 10.1016/S0140-6736(00)49915-0

[35] Characterization of circulating tumor cells from subjects with metastatic breast cancer using the CTC-endocrine therapy index: The COMETI-P2-2012.0 trial [J].

Paoletti, C. .

CANCER RESEARCH, 2013, 73

[36] Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients [J].

Rack, Brigitte ;

Schindlbeck, Christian ;

Jueckstock, Julia ;

Andergassen, Ulrich ;

Hepp, Philip ;

Zwingers, Thomas ;

Friedl, Thomas W. P. ;

Lorenz, Ralf ;

Tesch, Hans ;

Fasching, Peter A. ;

Fehm, Tanja ;

Schneeweiss, Andreas ;

Lichtenegger, Werner ;

Beckmann, Matthias W. ;

Friese, Klaus ;

Pantel, Klaus ;

Janni, Wolfgang .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (05)

[37] Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer [J].

Roth, Carina ;

Rack, Brigitte ;

Mueller, Volkmar ;

Janni, Wolfgang ;

Pantel, Klaus ;

Schwarzenbach, Heidi .

BREAST CANCER RESEARCH, 2010, 12 (06)

[38] HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy [J].

Santinelli, Alfredo ;

Pisa, Eleonora ;

Stramazzotti, Daniela ;

Fabris, Guidalberto .

INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (05) :999-1004

[39]

Schramm A, 2015, ASCOANNUMEET, V51, P266

[40] Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500 [J].

Smerage, Jeffrey B. ;

Barlow, William E. ;

Hortobagyi, Gabriel N. ;

Winer, Eric P. ;

Leyland-Jones, Brian ;

Srkalovic, Gordan ;

Tejwani, Sheela ;

Schott, Anne F. ;

O'Rourke, Mark A. ;

Lew, Danika L. ;

Doyle, Gerald V. ;

Gralow, Julie R. ;

Livingston, Robert B. ;

Hayes, Daniel F. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (31) :3483-+

← 1 2 3 4 5 →